SimBioSys

🎙 Listen to @jerskillington, CEO of @PoolbegPharma and Tushar Pandey, CEO and Co-founder of @SimBioSys, as they discuss the growing role of #AI in drug development on the latest episode of #OptimumPerspectives! Stream the full episode here: Optimum Perspectives Podcast – Optimum Strategic Communications (optimumcomms.com) and don't forget to subscribe on your favourite podcast platform so you never miss the latest updates from the #LifeScience community brought to you by #OptimumStrategicCommunications!

@CarlaFisherMD @CarlaFisherMD LOVE IT :) We should get TumorSight into that meeting :)

We love our radiology colleagues! Enjoying a joint discussion between surgery and radiology about localizations hits and misses!

We are thrilled to announce our first FDA 510(k) clearance for our digital precision medicine technology, TumorSight™! This milestone allows us to deliver on our vision to redefine precision medicine and revolutionize patient care. Read more here: businesswire.com/news/home/2024…

We are excited to announce a strategic collaboration with the @MayoClinic for the development of novel digital medicine solutions for patients to help improve quality of life, starting with #breastcancer. Read more about this exciting collaboration here: businesswire.com/news/home/2024…

It’s not too late to register for @DDWJournal's Cancer Summit! Join our CTO and Co-founder, Dr. Joseph Peterson, alongside other leaders in the field to discuss the latest advancements in cancer drug discovery research. Register here: register.gotowebinar.com/register/24536…

Interested in learning more about the latest advancements and tools in cancer drug discovery? Our CTO and Co-founder Dr. Joseph Peterson will be speaking alongside other leaders in the field during @DDWJournal's Cancer Summit! Register: register.gotowebinar.com/register/24536…

As our product pipeline continues to advance, now is the perfect time to update our website to reflect all of our important progress! Learn more about the exciting things happening, including the latest on our TumorSight and PhenoScope platforms: simbiosys.com

As #BreastCancerAwarenessMonth ends, we reflect on how we can better serve patients so that they may live longer & better. Dr. Barry Rosen shares how recent tech, including our TumorSight platform, can help ensure that patients receive the best care. tinyurl.com/nhcajebd

🎗️Today, on #MetastaticBreastCancerAwarenessDay, we raise awareness for the thousands of individuals battling this chronic disease. SimBioSys is dedicated to helping to individualize care and improve outcomes. Learn more to #LightUpMBC: metavivor.org/take-action/ca…

If you’re attending the conference, please be sure to attend our presentation with Joseph Peterson on Friday and stop by Booth #1 to learn more about how PhenoScope™ Discovery can help uniquely advance your cancer research capabilities.

Join us at the Spatial Biology for Drug Development Summit to explore how this rapidly changing technology is becoming a crucial component of successful drug development programs and how we can help. Learn more: spatialbiology-drugdevelopment.com

October is #BreastCancerAwarenessMonth. We've made much progress in treating this disease, but we can still do better. We’re developing our TumorSight technology to help doctors create treatment plans that are personalized for each patient – learn more: simbiosys.com

@SimBioSys CEO Tushar Pandey was interviewed in a recent episode of the CRPN Central Podcast. It's always great to hear from EnterpriseWorks tenants: listen to this podcast today at drfoxt.podbean.com/e/breast-cance….

Check out this recent @JournalofCP article by Matthew Biancalana and Tushar Pandey. They discuss how #AI can enhance the field of precision medicine and help unburden physicians from laborious and repetitive tasks in diagnostic analyses: hmpgloballearningnetwork.com/site/jcp/artif…

@oncodaily @JAMouabbi @LobularBCA Congratulations @JAMouabbi! Excited for a better future for ILC patients under your leadership.

@JAMouabbi @LobularBCA We are delighted to inform you that your post has been published on oncodaily.com Thank you for sharing! oncodaily.com/11483.html

Thrilled to announce that I’ve been chosen as the next SAB Chair of @LobularBCA! 🙌 Excited to work alongside dedicated experts and advocates in the field to advance research and support those affected by #lobular #breastcancer Together, we can make a difference!💪 @MDAndersonNews #EndCancer lobularbreastcancer.org/lbca-welcomes-…

This week CancerX announced its strategic priorities for 2023-2024 and its inaugural steering committee aligning their priorities with the broader Cancer Moonshot community. Learn about CancerX strategic priorities here: #strategic-priorities" target="_blank" rel="nofollow noopener">cancerx.health/about-cancerx/…

We are thrilled to be part of the Chicago biotech community supporting the CancerX initiative and partnering with @_DiMeSociety and @MoffittNews in the fight against #cancer. Read more about our involvement with the initiative as a founding member. chicagobusiness.com/health-care/ch…

If you are attending the #AGBT #PrecisionHealth meeting today, don’t miss out on the opportunity to connect with Dr. Daniel Cook during his poster presentation from 4:35 p.m. to 6:35 p.m. Learn more about our next-generation technology for #surgicalplanning.

We’re excited to showcase our #surgicalplanning platform at the @agbt #PrecisionHealth, an annual meeting that keeps bringing innovative technologies to light. Our Director of Bioinformatics & Metabolism, Dr. Daniel Cook, will present our technology tomorrow @ 4:35 p.m.-6:35 p.m.

Connect with our SimBioSys team at the 13th Annual #WorldCBCDx Summit! Learn more about our #spatialbiology approach for #biomarkerdevelopment in #oncology.